Evernorth, the health services division of Cigna, is debuting a pharmacy benefit management program geared to make Wegovy and Zepbound more available to patients by capping the amount they spend monthly on GLP-1 medications. Through negotiations with the medications’ manufacturers, Everborth said it will cap patient’s monthly cost at no more than $200. The goal, […]